API R&D Unit-III, Nacharam

API R&D Unit-III, Nacharam spans ~10,000 sq. ft. and offers end-to-end CDMO services for high-potent Payloads, APIs, and intermediates, supporting delivering integrated solutions from discovery to commercial manufacturing.

The team has deep expertise in developing validated processes for OEB-5 category compounds involving complex chemistries. The site also supports regulatory submissions for new products in regulated markets and develops as well as validates analytical methods for KSMs, intermediates, and APIs. In addition, the facility conducts carry-over investigations for GTIs, nitrosamines, and NDSRIs in pharmaceutical ingredients.

With a strong team of over 65 scientists, and more than 20 years of CDMO experience, the unit brings two decades of proven expertise in translating chemistry from lab-scale innovation to early-phase development, scale-up, and commercial manufacturing.